Loading...
XTAI
1760
Market cap182mUSD
Dec 05, Last price  
66.70TWD
1D
-1.48%
1Q
-8.88%
Jan 2017
-1.62%
IPO
258.60%
Name

Panion & BF Biotech Inc

Chart & Performance

D1W1MN
XTAI:1760 chart
P/E
45.93
P/S
2.82
EPS
1.45
Div Yield, %
2.25%
Shrs. gr., 5y
1.93%
Rev. gr., 5y
5.22%
Revenues
2.03b
+7.85%
559,396,000524,779,000584,249,000674,896,000857,082,0001,014,406,0001,205,065,0001,049,246,0001,212,478,0001,408,741,0001,573,944,0001,568,637,0001,901,211,0002,398,648,0001,881,875,0002,029,645,000
Net income
125m
+61.26%
5,088,000-39,305,000-36,260,000-40,562,00018,149,00048,269,00072,996,00089,720,00090,539,000159,171,000161,329,00027,901,000104,402,000182,345,00077,219,000124,523,000
CFO
351m
+97.94%
76,978,000-13,895,000-36,120,0003,958,00086,225,00076,111,00058,304,000177,217,000113,973,00078,584,00090,984,000-14,555,000401,225,000489,872,000177,418,000351,188,000
Dividend
Jun 13, 20241.5 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, manufactures and sells various pharmaceutical products in Taiwan. The company offers products in the areas of medical beauty, kidney, respiratory tract, gastrointestinal tract, and body and hair cleaning. It also provides oral drugs and topical preparations; hand and mechanical disinfection, body lotion, and skin disinfection products; and pet health products, including surgical and skin prescriptions. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei, Taiwan.
IPO date
Jun 14, 2004
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT